Oxyma Pure — Coupling Additive for Racemization-Free SPPS¶
Introduction¶
Oxyma Pure (ethyl 2-cyano-2-(hydroxyimino)acetate) is an auxiliary nucleophile used alongside carbodiimide activators in solid-phase peptide synthesis to suppress racemization and enhance coupling efficiency. First introduced as a safer alternative to HOBt, Oxyma has become the preferred additive in large-scale and GMP peptide manufacturing due to its non-explosive character, excellent racemization suppression, and high solubility in common SPPS solvents. Its synergistic combination with DIC produces an in situ activated ester that reacts rapidly with the resin-bound amine while minimising enantiomeric erosion at the α-carbon of the incoming amino acid.
Chemical and Physical Properties¶
| Property | Value |
|---|---|
| IUPAC name | Ethyl 2-cyano-2-(hydroxyimino)acetate |
| CAS number | 3849-21-6 |
| Molecular formula | C₅H₆N₂O₃ |
| Molecular weight | 142.11 g/mol |
| Appearance | White to off-white crystalline powder |
| Melting point | 140–145 °C (decomposes) |
| pKa (oxime OH) | ~4.8 |
| Solubility in DMF | >200 g/L (25 °C) |
| Solubility in DCM | ~30 g/L (25 °C) |
| Solubility in water | 8.8 g/L (20 °C) |
| UV absorption (λmax) | 274 nm (ε = 8,500 M⁻¹·cm⁻¹) |
Mechanism of Action¶
Oxyma functions through the formation of an exceptionally stable active ester intermediate. When combined with a carbodiimide such as DIC, the carboxylic acid of the Fmoc-amino acid is rapidly converted to the corresponding O-acylisourea. In the absence of an auxiliary nucleophile, this O-acylisourea can undergo racemization via oxazolone formation or interconversion to the unreactive N-acylurea. Oxyma intercepts the O-acylisourea before these side reactions occur:
- DIC + Fmoc-AA-OH → O-acylisourea (fast, <1 min)
- O-acylisourea + Oxyma → Oxyma ester + diisopropylurea (fast)
- Oxyma ester + H₂N-peptide-resin → peptide bond + Oxyma (rate-limiting, 30–60 min)
The Oxyma ester is kinetically competent—it reacts with amines at a comparable rate to HOBt esters—but the cyano-oxime structure confers an additional racemization-suppression effect by disfavouring oxazolone formation.
Racemization Suppression Data¶
Comparative racemization levels across common coupling systems (measured by HPLC after segment coupling of Z-Gly-Phe-OH; racemization as % of D-Phe isomer):
| Coupling System | Racemization (%) | Notes |
|---|---|---|
| DIC alone | 8–14 | Unacceptable; oxazolone pathway dominant |
| DIC + HOBt (1:1) | 0.3–1.2 | Acceptable for most sequences |
| DIC + Oxyma (1:1) | 0.2–0.8 | Superior suppression, comparable to HOBt |
| DIC + HOAt (1:1) | 0.1–0.4 | Best suppression but high cost |
| HBTU/DIEA | 0.5–2.0 | Base-dependent; higher at elevated temperature |
| HATU/DIEA | 0.1–0.6 | Gold standard for hindered couplings |
Oxyma matches or exceeds HOBt in racemization suppression across all tested amino acid types. The improvement is most pronounced for Cys, His, and Ser derivatives where base-catalysed racemization pathways are most active.
Compatibility Comparison — Oxyma vs. HOBt¶
| Feature | Oxyma | HOBt |
|---|---|---|
| Explosion hazard | None (DSC exotherm >250 °C) | Shock-sensitive at >5 g scale |
| Transportation restriction | None (not classified as explosive) | IATA Class 1 (explosive) for bulk |
| Shelf life (2–8 °C, anhydrous) | >2 years | >1 year |
| Solubility in DMF | >200 g/L | ~80 g/L |
| UV activity at 214 nm | Moderate | Moderate |
| Cost per mol | Moderate | Low |
| Byproduct after coupling | Cyano-oxime (benign) | Benzotriazole (potential irritant) |
| GMP compatibility | Yes (widely accepted) | Restricted at scale |
| Green chemistry rating | Excellent (no toxic metals) | Good |
Recommended Usage Ratios¶
The standard protocol in Fmoc SPPS with DIC/Oxyma activation uses the following stoichiometry:
| Component | Equivalents (vs. resin loading) | Solvent | Time |
|---|---|---|---|
| Fmoc-amino acid | 3 eq | DMF (or DMF/DCM 1:1) | — |
| Oxyma | 3 eq | Same as amino acid solution | — |
| DIC | 3 eq | Added last, then vortex | — |
| Pre-activation | — | 2–5 min at RT | — |
| Coupling | — | — | 30–60 min |
Variations by coupling difficulty:
| Sequence Feature | Recommended Adjustment |
|---|---|
| Standard amino acid | 3 eq DIC + 3 eq Oxyma, 30 min |
| Sterically hindered (Aib, D-AA) | 5 eq DIC + 5 eq Oxyma, 60–90 min, 50 °C |
| After Arg(Pbf) coupling | Double coupling, 3+3 eq, 45 min each |
| β-branched (Ile, Val) | 4 eq, 60 min, monitor by Kaiser test |
| Long peptide (>30 AA) | Reduce to 2 eq to minimize deletion sequences |
Handling and Storage¶
- Storage: 2–8 °C in a tightly sealed container, protected from moisture and light
- Stability: >2 years under recommended conditions; avoid prolonged exposure to air (hygroscopic)
- Handling: Normal laboratory PPE (gloves, safety glasses). No special explosion-proof precautions required
- Solubility: Prepare stock solutions in DMF (0.5–1.0 M); warm gently if crystals form
- Disposal: Aqueous waste acceptable; Oxyma byproducts are non-toxic and biodegradable
Key Considerations for Process Development¶
- Avoid excess DIC: Using >3 eq DIC relative to the amino acid can promote N-acylurea formation. Maintain a 1:1 DIC:Oxyma molar ratio.
- Monitor by TLC or HPLC: Unreacted amino acid appears as a ninhydrin-negative spot but Oxyma may form coloured complexes — use Kaiser or chloranil test for primary amine detection.
- Temperature sensitivity: Oxyma decomposes above 150 °C. This is well above any SPPS process temperature but relevant for thermal analysis in scale-up safety assessments.
- Resin compatibility: Works equally well with all common SPPS resins (Wang, Rink Amide, 2-Cl-Trt, Sieber). No special resin pre-treatment required.
Specifications for Procurement¶
| Grade | Purity | Water Content | Appearance | Typical Use |
|---|---|---|---|---|
| Standard (for SPPS) | ≥99.0% | ≤0.5% | White powder | Routine coupling |
| High-purity (for GMP) | ≥99.5% | ≤0.1% | White crystalline | GMP manufacturing |
| ACS grade | ≥98.0% | ≤1.0% | Off-white | Research only |
🔗 Related: DIC | HBTU | Coupling Reagent Comparison | Coupling Reaction | Custom Peptide Synthesis — Quality Standards